Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-008412·Aspire Biopharma Holdings, Inc.
Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Common Stock · CUSIP: 738920107
Event date: 2025-02-17
- Filing-level shares
- 4,883,375.00
- Percent of class
- 9.98%
- Lance Friedman
Shares: 4,883,375.00 · Class: 9.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-008412
- Form type
- SCHEDULE 13G
- Filer
- Aspire Biopharma Holdings, Inc.
- CIK
- CIK 1847345
- Filed
- Feb 26, 2025
- Reporting period
- Feb 17, 2025
- Description
- Schedule 13G beneficial ownership